Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein - PubMed (original) (raw)
Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein
R J Tritch et al. J Virol. 1991 Feb.
Abstract
The virally encoded protease of human immunodeficiency virus (HIV) is responsible for specific cleavage events leading to the liberation of the enzymes reverse transcriptase, integrase, ribonuclease H, and the core proteins from the gag-pol and gag polyprotein precursors. Utilizing gag polyprotein synthesized in vitro, we have shown that this substrate is sequentially cleaved by purified HIV protease to yield products that on the basis of their sizes and immunoreactivities correspond to p15, p6, p7, p17, and finally mature p24. We have placed unique restriction sites flanking the p17-p24 domain in order to facilitate replacement of cleavage site sequences by utilizing oligonucleotide cassettes. Replacement of the rapidly cleaved methionine-methionine bond at the p24-p15 junction with tyrosine-proline or replacement of the tyrosine-proline bond at the p17-p24 junction with methionine-methionine results in sites that cannot be efficiently cleaved. A basic amino acid at the p17-p24 scissile bond is not tolerated. Replacement of this cleavage site with an inverted repeat amino acid sequence gives intermediate rates of cleavage. In an attempt to convert the p17-p24 domain into a p24-p15 domain, residues flanking the scissile bond were exchanged in an expanding iterative fashion. When four residues flanking the scissile bond had been replaced, the rate of cleavage relative to that of the native p17-p24 sequence was increased fourfold. The cleavage rate of the native p24-p15 sequence is still some 10-fold greater than that of the p17-p24 sequence, suggesting that more-distant residues significantly affect the cleavage rate.
Similar articles
- Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
Erickson-Viitanen S, Manfredi J, Viitanen P, Tribe DE, Tritch R, Hutchison CA 3rd, Loeb DD, Swanstrom R. Erickson-Viitanen S, et al. AIDS Res Hum Retroviruses. 1989 Dec;5(6):577-91. doi: 10.1089/aid.1989.5.577. AIDS Res Hum Retroviruses. 1989. PMID: 2692658 - Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM. Goodenow MM, et al. Virology. 2002 Jan 5;292(1):137-49. doi: 10.1006/viro.2001.1184. Virology. 2002. PMID: 11878916 - HIV-1 replication.
Freed EO. Freed EO. Somat Cell Mol Genet. 2001 Nov;26(1-6):13-33. doi: 10.1023/a:1021070512287. Somat Cell Mol Genet. 2001. PMID: 12465460 Review. - Morphogenesis of human immunodeficiency virus type 1.
Chatterjee S, Basak S, Khan NC. Chatterjee S, et al. Pathobiology. 1992;60(4):181-6. doi: 10.1159/000163721. Pathobiology. 1992. PMID: 1388714 Review.
Cited by
- A myristoyl switch at the plasma membrane triggers cleavage and oligomerization of Mason-Pfizer monkey virus matrix protein.
Častorálová M, Sýs J, Prchal J, Pavlů A, Prokopová L, Briki Z, Hubálek M, Ruml T. Častorálová M, et al. Elife. 2024 Mar 22;13:e93489. doi: 10.7554/eLife.93489. Elife. 2024. PMID: 38517277 Free PMC article. - Chitosan-Based Nanoparticles Against Viral Infections.
Boroumand H, Badie F, Mazaheri S, Seyedi ZS, Nahand JS, Nejati M, Baghi HB, Abbasi-Kolli M, Badehnoosh B, Ghandali M, Hamblin MR, Mirzaei H. Boroumand H, et al. Front Cell Infect Microbiol. 2021 Mar 17;11:643953. doi: 10.3389/fcimb.2021.643953. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33816349 Free PMC article. Review. - HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
Potempa M, Lee SK, Kurt Yilmaz N, Nalivaika EA, Rogers A, Spielvogel E, Carter CW Jr, Schiffer CA, Swanstrom R. Potempa M, et al. J Mol Biol. 2018 Dec 7;430(24):5182-5195. doi: 10.1016/j.jmb.2018.10.022. Epub 2018 Nov 7. J Mol Biol. 2018. PMID: 30414407 Free PMC article. - Quenching protein dynamics interferes with HIV capsid maturation.
Wang M, Quinn CM, Perilla JR, Zhang H, Shirra R Jr, Hou G, Byeon IJ, Suiter CL, Ablan S, Urano E, Nitz TJ, Aiken C, Freed EO, Zhang P, Schulten K, Gronenborn AM, Polenova T. Wang M, et al. Nat Commun. 2017 Nov 24;8(1):1779. doi: 10.1038/s41467-017-01856-y. Nat Commun. 2017. PMID: 29176596 Free PMC article. - Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
Teto G, Tagny CT, Mbanya D, Fonsah JY, Fokam J, Nchindap E, Kenmogne L, Njamnshi AK, Kanmogne GD. Teto G, et al. Sci Rep. 2017 Oct 26;7(1):14136. doi: 10.1038/s41598-017-14095-4. Sci Rep. 2017. PMID: 29074854 Free PMC article.
References
- Nature. 1987 Sep 24-30;329(6137):351-4 - PubMed
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- Methods Enzymol. 1987;154:367-82 - PubMed
- AIDS Res Hum Retroviruses. 1987 Fall;3(3):253-64 - PubMed
- Proc Natl Acad Sci U S A. 1988 Apr;85(8):2449-53 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials